Girolomoni, Giampiero http://orcid.org/0000-0001-8548-0493
Savage, Laura http://orcid.org/0000-0002-8283-6519
Gisondi, Paolo http://orcid.org/0000-0002-1777-9001
Svensson, Åke
Mahé, Emmanuel http://orcid.org/0000-0001-5780-1827
Augustin, Matthias
Puig, Luis http://orcid.org/0000-0001-6083-0952
Funding for this research was provided by:
Biogen
Article History
Received: 15 June 2023
Accepted: 14 August 2023
First Online: 14 September 2023
Declarations
:
: GG has received personal fees from AbbVie, Abiogen, Almirall, Amgen, Biogen, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli-Lilly, Leo Pharma, Merck Serono, Novartis, Pfizer, Samsung and Sanofi. LS has received honoraria and/or received research funding from the following pharmaceutical companies: AbbVie, Almirall, Amgen, Aspire Pharma, Biogen, Boehringer-Ingelheim, Bristol-Myers-Squibb, Celgene, Celltrion, Fresensius Kabi, Galderma, Janssen, Leo, Lilly, Novartis, Pfizer, MSD, Sanofi, Takeda, UCB. PG has been a consultant and/or speaker for Abbvie, Almirall, Celgene, Ducray, Janssen, LEO Pharma, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Pierre Fabre, Sandoz, UCB. ÅS has no disclosures to declare. EM has received grants or contracts from Sanofi and Abbvie; Consulting fees from Sanofi and Abbvie. MA has received research grants from AbbVie, Almirall, Beiersdorf, Eli Lilly, Galderma, Incyte, LEO, Menlo, MSD, Novartis, Pfizer, Regeneron, Sanofi‐Genzyme and Trevi; served as a consultant for AbbVie, Almirall, Beiersdorf, Eli Lilly, Galderma, Incyte, LEO, Menlo, MSD, Novartis, Pfizer, Regeneron, Sanofi‐Genzyme and Trevi; and as a lecturer for AbbVie, Almirall, Beiersdorf, Eli Lilly, Galderma, Incyte, LEO, Menlo, MSD, Novartis, Pfizer, Regeneron, Sanofi‐Genzyme and Trevi. LP has received consultancy/speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, Baxalta, Biogen, Boehringer- Ingelheim, Celgene, Gebro, Janssen, JSC BIOCAD, Leo-Pharma, Lilly, Merck-Serono, MSD, Mylan, Novartis, Pfizer, Regeneron, Roche, Sandoz, Samsung-Bioepis, Sanofi and UCB.
: This article does not contain any new studies with human or animal subjects performed by any of the authors.